Adult T-cell Leukemia/lymphoma - 89 Studies Found
| Withdrawn |
: Donor T Cells, Low-Dose Aldesleukin, and Low-Dose GM-CSF After Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma : Lymphoma : 2007-08-24 : Biological: anti-CD3 x anti-CD20 bispecific antibody-armed activated T cells |
| Completed |
: Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment :
: 2007-02-15 : Drug: Everolimus Everolimus 10 mg orally daily for 4 week cycle. Repeat until progression, unacceptable |
| Completed |
: SL-11047 in Treating Patients With Relapsed or Refractory Lymphoma : Lymphoma : 2006-02-16 : Drug: polyamine analogue PG11047 |
| Terminated |
: Reduced-Intensity Regimen Before Allogeneic Transplant for Patients With Relapsed Non-Hodgkin's or Hodgkin's Lymphoma : Lymphoma : 2003-04-07 :
|
| Completed |
: Bryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's Lymphoma :
: 2000-05-02 :
|
| Completed |
: Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's Lymphoma : Lymphoma : 2000-04-06 : Drug: arsenic trioxide |
| Completed |
: 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery :
: 1999-12-10 : Drug: tanespimycin |
| Completed |
: Paclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphomas :
: 1999-12-10 :
|
| Completed |
: Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma :
|